Naoyuki Harada

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Takashi Ohtsuka

> Home > Persons > Naoyuki Harada

Publications

2004
[c4]
- no documents available
  - no references & citations available
- export record
  dblp key:
  - conf/cars/SugoYHAKMOOTS04
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/cars/SugoYHAKMOOTS04
Nobuo Sugo, Kyousuke Yokota, Naoyuki Harada, Yoshinori Aoki, Toshiyuki Kano, Chikao Miyazaki, Takashi Ohtsuka, Hitoshi Ohishi, K. Tachiki, Y. Seiki:
Evaluation of the volume in peritumoral hypoperfusion area surrounding brain tumor using three-dimensional 123I-IMP SPECT. CARS 2004: 1257
[c3]
- no documents available
  - no references & citations available
- export record
  dblp key:
  - conf/cars/SugoYHAKMOOTS04a
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/cars/SugoYHAKMOOTS04a
Nobuo Sugo, Kyousuke Yokota, Naoyuki Harada, Yoshinori Aoki, Toshiyuki Kano, Chikao Miyazaki, Takashi Ohtsuka, Hitoshi Ohishi, K. Tachiki, Y. Seiki:
Early dynamic thallium-201 SPECT in evaluation of glioma. CARS 2004: 1258
[c2]
- no documents available
  - no references & citations available
- export record
  dblp key:
  - conf/cars/SugoYHAKMOOTS04b
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/cars/SugoYHAKMOOTS04b
Nobuo Sugo, Kyousuke Yokota, Naoyuki Harada, Yoshinori Aoki, Toshiyuki Kano, Chikao Miyazaki, Takashi Ohtsuka, Hitoshi Ohishi, K. Tachiki, Y. Seiki:
The integrated three-dimensional image of SPECT and MRI in malignant glioma. CARS 2004: 1259

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.